Cargando…

Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation

BACKGROUND: Rare cancers account for approximately 24% of all new cancers. The category of rare tumor diseases includes almost 200 different entities. In particular, the treatment of patients with extensive care needs requires cooperation between service providers, both between sectors (outpatient a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinneburg, Jana, Zacher, Sandro, Berger-Höger, Birte, Berger-Thürmel, Karin, Kratzer, Vanessa, Steckelberg, Anke, Lühnen, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603554/
https://www.ncbi.nlm.nih.gov/pubmed/37824180
http://dx.doi.org/10.2196/49731
_version_ 1785126629820858368
author Hinneburg, Jana
Zacher, Sandro
Berger-Höger, Birte
Berger-Thürmel, Karin
Kratzer, Vanessa
Steckelberg, Anke
Lühnen, Julia
author_facet Hinneburg, Jana
Zacher, Sandro
Berger-Höger, Birte
Berger-Thürmel, Karin
Kratzer, Vanessa
Steckelberg, Anke
Lühnen, Julia
author_sort Hinneburg, Jana
collection PubMed
description BACKGROUND: Rare cancers account for approximately 24% of all new cancers. The category of rare tumor diseases includes almost 200 different entities. In particular, the treatment of patients with extensive care needs requires cooperation between service providers, both between sectors (outpatient and inpatient) and within sectors (eg, between different medical disciplines). The treatment pathway is associated with a high need for coordination and information sharing between providers. When crossing sectoral boundaries in the German health care system, interface problems between the outpatient and inpatient sectors can lead to gaps in care delivery. The multicomponent program Trans-sectoral Personalised Care Concept for Patients with Rare Cancers aims to optimize transsectoral cooperation and coordination of care to enhance patient involvement and the medical care coordination of patients with rare cancers. OBJECTIVE: This process evaluation will contribute to answering questions about intervention fidelity and the implementation of transsectoral communication, identifying and describing the intended and nonintended effects of the intervention, and exploring the barriers to and facilitators of the implementation. METHODS: We will include patients who participate in the intervention phase; all persons and staff involved in the development and implementation of the intervention (Onco Coach, psychologists, physicians on the contact platform, IT staff, and staff of the Bavarian Association of Statutory Health Insurance Physicians); physicians from the Ludwig-Maximilians-University Hospital Munich and the hospital of the Technical University Munich who are involved in the treatment of patients during the course of the project; and participating office–based hematologists and oncologists. Data collection will be conducted at the beginning, during, and at the end of the intervention using mixed methods. Data will be collected from questionnaires, document analyses, semistructured interviews, and structured observations and will cover different aspects of process evaluation. These include examining the context to explore existing patterns, changes in patterns, attitudes, and interactions; analyzing the implementation of intervention elements; and exploring the complex causal pathways and mediators of the intervention. Qualitative data will be analyzed using thematic analysis. The data will then be combined using between-methods triangulation. RESULTS: This project received funding on March 1, 2022. The intervention phase and recruitment for the process evaluation began on March 1, 2023, and the recruitment is expected to end on September 30, 2025. At the time of protocol submission in June 2023, a total of 8 doctors from hematology and oncology practices were enrolled. Data collection began on March 14, 2023. CONCLUSIONS: The Trans-sectoral Personalised Care Concept for Patients with Rare Cancers project is a complex intervention that is to be implemented in an equally complex health care context. The process evaluation will help understand the influence of contextual factors and assess the mechanisms of change. TRIAL REGISTRATION: ISRCTN registry ISRCTN16441179; https://doi.org/10.1186/ISRCTN16441179 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/49731
format Online
Article
Text
id pubmed-10603554
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-106035542023-10-28 Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation Hinneburg, Jana Zacher, Sandro Berger-Höger, Birte Berger-Thürmel, Karin Kratzer, Vanessa Steckelberg, Anke Lühnen, Julia JMIR Res Protoc Protocol BACKGROUND: Rare cancers account for approximately 24% of all new cancers. The category of rare tumor diseases includes almost 200 different entities. In particular, the treatment of patients with extensive care needs requires cooperation between service providers, both between sectors (outpatient and inpatient) and within sectors (eg, between different medical disciplines). The treatment pathway is associated with a high need for coordination and information sharing between providers. When crossing sectoral boundaries in the German health care system, interface problems between the outpatient and inpatient sectors can lead to gaps in care delivery. The multicomponent program Trans-sectoral Personalised Care Concept for Patients with Rare Cancers aims to optimize transsectoral cooperation and coordination of care to enhance patient involvement and the medical care coordination of patients with rare cancers. OBJECTIVE: This process evaluation will contribute to answering questions about intervention fidelity and the implementation of transsectoral communication, identifying and describing the intended and nonintended effects of the intervention, and exploring the barriers to and facilitators of the implementation. METHODS: We will include patients who participate in the intervention phase; all persons and staff involved in the development and implementation of the intervention (Onco Coach, psychologists, physicians on the contact platform, IT staff, and staff of the Bavarian Association of Statutory Health Insurance Physicians); physicians from the Ludwig-Maximilians-University Hospital Munich and the hospital of the Technical University Munich who are involved in the treatment of patients during the course of the project; and participating office–based hematologists and oncologists. Data collection will be conducted at the beginning, during, and at the end of the intervention using mixed methods. Data will be collected from questionnaires, document analyses, semistructured interviews, and structured observations and will cover different aspects of process evaluation. These include examining the context to explore existing patterns, changes in patterns, attitudes, and interactions; analyzing the implementation of intervention elements; and exploring the complex causal pathways and mediators of the intervention. Qualitative data will be analyzed using thematic analysis. The data will then be combined using between-methods triangulation. RESULTS: This project received funding on March 1, 2022. The intervention phase and recruitment for the process evaluation began on March 1, 2023, and the recruitment is expected to end on September 30, 2025. At the time of protocol submission in June 2023, a total of 8 doctors from hematology and oncology practices were enrolled. Data collection began on March 14, 2023. CONCLUSIONS: The Trans-sectoral Personalised Care Concept for Patients with Rare Cancers project is a complex intervention that is to be implemented in an equally complex health care context. The process evaluation will help understand the influence of contextual factors and assess the mechanisms of change. TRIAL REGISTRATION: ISRCTN registry ISRCTN16441179; https://doi.org/10.1186/ISRCTN16441179 INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/49731 JMIR Publications 2023-10-12 /pmc/articles/PMC10603554/ /pubmed/37824180 http://dx.doi.org/10.2196/49731 Text en ©Jana Hinneburg, Sandro Zacher, Birte Berger-Höger, Karin Berger-Thürmel, Vanessa Kratzer, Anke Steckelberg, Julia Lühnen, TARGET Group. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 12.10.2023. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on https://www.researchprotocols.org, as well as this copyright and license information must be included.
spellingShingle Protocol
Hinneburg, Jana
Zacher, Sandro
Berger-Höger, Birte
Berger-Thürmel, Karin
Kratzer, Vanessa
Steckelberg, Anke
Lühnen, Julia
Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation
title Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation
title_full Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation
title_fullStr Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation
title_full_unstemmed Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation
title_short Enhancing Transsectoral Interdisciplinary Patient-Centered Care for Patients With Rare Cancers: Protocol for a Mixed Methods Process Evaluation
title_sort enhancing transsectoral interdisciplinary patient-centered care for patients with rare cancers: protocol for a mixed methods process evaluation
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10603554/
https://www.ncbi.nlm.nih.gov/pubmed/37824180
http://dx.doi.org/10.2196/49731
work_keys_str_mv AT hinneburgjana enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation
AT zachersandro enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation
AT bergerhogerbirte enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation
AT bergerthurmelkarin enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation
AT kratzervanessa enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation
AT steckelberganke enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation
AT luhnenjulia enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation
AT enhancingtranssectoralinterdisciplinarypatientcenteredcareforpatientswithrarecancersprotocolforamixedmethodsprocessevaluation